期刊文献+

荧光素酶标记的重组A/WSN/33(H1N1)流感病毒的构建

Construction of recombinant A / WSN /33( H1N1) influenza viruses labeled with luciferases
原文传递
导出
摘要 目的构建表达荧光素酶的A型流感病毒反向遗传操作系统,对研究流感病毒的致病机制、抗病毒药物筛选、中和抗体检测以及病毒在动物体内的实时监测都具有重要意义。方法本文利用融合PCR方法,在A/WSN/33(H1N1)毒株NA基因的N端插入Gaussia荧光素酶(GLUC)或Renllia荧光酶(RLUC)报告基因编码序列,分别构建能表达GLUC或RLUC的重组NA质粒。将构建好的重组NA质粒替换A/WSN/33(H1N1)8质粒反向遗传操作系统中的NA基因,进行表达荧光素酶报告基因病毒的拯救。结果经过Western blot和荧光素酶活性检测等方法验证,分别成功获得了表达GLUC或RLUC的2株重组病毒;P0代上清感染MDCK后,仍能通过免疫荧光技术检测到NP蛋白的表达。结论这种表达LUC的流感病毒系统将会成为流感的基础性研究和应用性研究的有利工具,尤其是GLUC作为一种分泌型的荧光素酶,可以通过体外监测重组病毒GLUC的表达来实时监测流感病毒在体内的感染过程。 Objective Construction of luciferase of type A influenza virus reverse genetic operating system for the study of influenza virus pathogenesis and antiviral drug screening,neutralizing antibody detection and virus in vivo real- time monitoring has important significance. Methods In this study,we used the fusion PCR method,the Gaussia luciferase( GLUC) or Renllia luciferase( RLUC) were inserted in the ends of the A / WSN /33( H1N1) NA gene N to report gene encoding sequence and recombinant NA plasmid expressing GLUC or RLUC were constructed,respectively. The constructed recombinant NA plasmid replaced the NA gene in the A / WSN /33( H1N1) 8 plasmid reverse genetic operating system to ave the expression of luciferase reporter gene.Results After Western blot and luciferase activity assay,2 recombinant viruses expressing GLUC or RLUC were successfully obtained; the expression of NP protein was detected by immunofluorescence technique after infection of MDCK cells in P〈0 cells.Conclu sion The LUC flu virus system will be a powerful tool for basic research and applied research of influenza. Especially,GLUC as a secreted type of luciferase can be used to perform real- time monitoring of the infection process in vivo by monitoring the expression of recombinant virus GLUC in vivo.
出处 《中国卫生检验杂志》 CAS 2015年第15期2559-2563,共5页 Chinese Journal of Health Laboratory Technology
关键词 A型流感病毒 反向遗传学 荧光素酶 2A蛋白酶 神经氨酸酶 Influenza A virus Reverse genetics Luciferase 2A protease Neuraminidase
  • 相关文献

参考文献21

  • 1Palese P, Shaw ML. Fields Virology[ M]. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1647 -1689.
  • 2Zhu X, Xu X, Wilson IA. Structure determination of the 1918 H1N1 neuraminidase from a crystal with lattice -translocation defects [ J ]. Acta Crystallogr D Biol Crystallogr, 2008, 64 ( 8 ) : 843 - 850.
  • 3Huang RTC, Dietseh E, Rott R. Further studies on the role of neuraminidase and the mechanism of low pH dependence in influen- za virus- induced membrane fusion[ J]. J Gen Virul, 1985, 66 (2) : 295 -301.
  • 4Gonzalo RM, Rodrfguez D, Garcia- Sastre A, et al. Enhanced CD8 + T cell response to HIV - 1 env by combined immunization with influenza and vaccinia virus recombinants [ J ]. Vaccine, 1999, 17(7/8) : 887 -892.
  • 5Li S, Rodrigues M, Rodriguez D, et al. Priming with recombinant influenzavirus followed by administration of recombinant vaccinia vi- rus induces CD8 + T - cell - mediated protective immunity against malaria[J]. Proc Natl Acad Sci USA, 1993, 90( 11 ) : 5214 - 5218.
  • 6Castrucci MR, Bilsel P, Kawaoka Y. Attenuation of influenza A vi- rus by insertion of a foreign epitope into the neuraminidase [ J ]. J Virol, 1992, 66(8) : 4647 -4653.
  • 7Efferson CL, Schickli J, Ko BK, et al. Activation of tumor antigen specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER -2/neu proto -oncogene[ J]. J Virol, 2003, 77(13) : 7411 -7424.
  • 8Muster T, Ferko B, Klima A, et al. Mucosal model of immuniza- tion against human immunodeficiency virus type 1 with a chimeric influenza virus[ J]. J Virol, 1995, 69 ( 11 ) : 6678 - 6686.
  • 9Liu QF, Wang S, Ma GP, et al. Improved and simplified recom- bineering approach for influenza virus reverse genetics [ J ]. J Mol Genet Med, 2009, 3(2) : 225 -231.
  • 10Neumann G, Watanabe T, Ito H, et al. Generation of influenza A viruses entirely from cloned cDNAs[J]. Proc Natl Acad Sci USA, 1999, 96( 16): 9345-9350.

二级参考文献23

  • 1Liu F, Song YK, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther, 1999, 6(7): 1258-1266.
  • 2Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA, 2002, 99(21): 13825-13830.
  • 3Cheng G, Davis RE. An improved and secreted luciferase reporter for schistosomes. Mol Biochem Parasitol, 2007, 155(2): 167-171.
  • 4Wurdinger T, Badr C, Pike L, et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods, 2008, 5(2): 171-173.
  • 5Tannous BA, Kim DE, Fernandez JL, et al. Codon-optimized gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther, 2005, 11(3): 435-443.
  • 6Sebestyen MG, Budker VG, Budker T, et al. Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med, 2006, 8(7): 852-873.
  • 7Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther, 2007, 15(12): 2063-2069.
  • 8Argyros O, Wong SP, Niceta M, et al. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Ther, 2008, 15(24): 1593-1605.
  • 9Hyoudou K, Nishikawa M, Umeyama Y, et al. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin CancerRes, 2004, 10(15): 7685-7691.
  • 10Rossmanith W, Chabicovsky M, Herkner K, et al. Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol, 2002, 21(11): 847-853.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部